Vital KSK Holdings, Inc.
Stock Price Chart
2026/03/03 UpdatedPrice Trend
2026/03/03 UpdatedPrice & Trading Details
2026/03/03 UpdatedPRICE
TRADING
Earnings Calendar
Updated 2026/03/01Recent Earnings
| Date | EPS Est. | EPS Actual | Surprise |
|---|---|---|---|
| 2016/02/04 | ¥30.31 | ¥49.91 | +64.7% |
| 2015/08/04 | ¥15.11 | ¥16.60 | +9.8% |
| 2015/05/13 | ¥8.69 | ¥8.51 | -2.0% |
| 2015/02/04 | ¥21.81 | ¥27.24 | +24.9% |
Shareholder Composition
Updated 2026/03/01Major Holders
Updated 2026/03/01| Institution | Ownership | Shares | Change |
|---|---|---|---|
|
VANGUARD STAR FUNDS-Vanguard Total International Stock Index Fund
|
479.0K | 0.00% | |
|
VANGUARD TAX-MANAGED FUNDS-Vanguard Developed Markets Index Fund
|
287.6K | 0.00% | |
|
DFA INVESTMENT TRUST CO-The Japanese Small Company Series
|
192.1K | -15.37% | |
|
DFA INVESTMENT DIMENSIONS GROUP INC-Intl Core Eqy. 2 PORT.
|
189.0K | -8.34% | |
|
Dimensional ETF Trust-Dimensional International Small Cap Value ETF
|
171.9K | +15.60% | |
|
DFA INVESTMENT DIMENSIONS GROUP INC-DFA Intl Small Cap Value PORT.
|
142.6K | +14.35% |
Dividend History 1Years Growth
Updated 2026/03/01| Year | Dividend | Change |
|---|---|---|
| 2025 | ¥58 | +31.8% |
| 2024 | ¥44 | -4.3% |
| 2023 | ¥46 | +76.9% |
| 2022 | ¥26 | +116.7% |
| 2021 | ¥12 | - |
Financial Performance
2026/03/01 UpdatedNo financial data available
Latest IR Information
-
(Correction) Partial Correction Regarding "Notice on Expansion of Shareholder Benefit Program"
An error was identified in part of the notice on the expansion of the shareholder benefit program published on 2026-02-26, resulting in corrections to the classification of number of shares held and other details.
Read more -
Notice Regarding Expansion of Shareholder Benefit Program
The shareholder benefit program will be expanded effective from the record date of March 31, 2026. Increases in QUO card grant amounts and the addition of options for gift items or donations will strengthen benefits for medium- to long-term shareholders.
Read more -
Fiscal Year Ending March 2026 Q3 Financial Summary [Japanese GAAP] (Consolidated)
For the third quarter of the fiscal year ending March 2026, net sales were 464,554 million yen (0.8% increase YoY), operating income was 3,119 million yen (42.3% decrease YoY), and net income attributable to owners of the parent for the...
Read more
Latest News (5 items)
Company Information
About
Vital KSK Holdings, Inc. engages in the wholesale and retail sale of pharmaceutical products in Japan. The company sells poisonous or deleterious substances, narcotics, quasi-drugs, medical equipment and devices, sanitary materials, hygiene goods, nursing care products, and beverages; and test reagents, agricultural chemicals, epidemiological agents and materials, industrial chemicals, veterinary drugs, poisonous and deleterious substances, paints, pigments, dyes, regenerative medicine products, and other chemicals, as well as well as chemicals for scientific use. It is also involved in the operation pharmacies; provision of medical management consulting services for medical institutions such as hospitals, nursing care providers, and local governments; wholesale of agricultural chemicals and agricultural materials; nursing care-related business; rental and sales of welfare equipment and home modification; general freight vehicle transportation activities; and insurance agency, real estate management, and parking lot operation businesses.Vital KSK Holdings, Inc. was incorporated in 2009 and is headquartered in Setagaya, Japan.
